EU H2020 Project "ATHERO MPH PROLIFERATION (Macrophage proliferation and ontogeny in murine models of atherosclerosis)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/196049/index.html

Athero MPh proliferation project word cloud

Explore the words cloud of the Athero MPh proliferation project. It provides you a very rough idea of what is the project "Athero MPh proliferation" about.

recruitment stromal mainly apart introduce originate clonal mechanisms localization macrophages eminent central interventions notion causes trans transfers strategy versus view quantifying lack expansion smooth recruited contribution therapeutic muscle progressing function intraplaque circulating formed cell reveal subverted question models bone accumulation assessing quantify pathogenesis fate vascular monocytes regression lysmcre local regions transcriptomics differentiated marrow mice society makeup western inflammatory plaque adoptive myeloid launching lipidomics wt proliferative death link underlies couple slowly cells versa ubow conclusively unclear capacity progression intervention course macrophage transcriptional phenotype vice disease atherosclerotic proliferation deploy atherosclerosis compare model lipidic proliferated invaded experimental resident animal mapping monocyte relative mouse first

Project "Athero MPh proliferation" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITEIT MAASTRICHT Organization address address: Minderbroedersberg 4-6 city: MAASTRICHT postcode: 6200 MD website: http://www.maastrichtuniversity.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Project website	https://pathologie.mumc.nl/nl/medewerkers/goossens
Total cost	177˙598 €
EC max contribution	177˙598 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2014
Funding Scheme	MSCA-IF-EF-ST
Starting year	2016
Duration (year-month-day)	from 2016-02-01 to 2018-01-31

#	participants	country	role	EC contrib. [€]
1	UNIVERSITEIT MAASTRICHT	NL (MAASTRICHT)	coordinator	177˙598.00

UNIVERSITEIT MAASTRICHT

NL (MAASTRICHT)

coordinator

177˙598.00

Project objective

Atherosclerosis is a slowly progressing inflammatory disease that underlies some of the most common causes of death in western society. The central role of macrophages throughout its pathogenesis makes this cell an eminent target for therapeutic intervention. Recent studies have subverted the classical view that atherosclerotic plaque macrophages mainly originate from recruited circulating monocytes, launching the new notion that macrophages could also be derived from clonal expansion of resident macrophages or even trans-differentiated vascular smooth muscle cells. The relative importance of these mechanisms to the pathogenesis remains however unclear, due to a lack of adequate animal models that allow assessing this question. In this project, I introduce a recently developed fate mapping model, the LysMCre-Ubow/ mouse, into the atherosclerosis field to conclusively identify regions within the plaque that were formed through local proliferation rather than monocyte recruitment. Apart from quantifying its relative contribution to plaque growth during disease progression and regression, I will furthermore characterize the localization, transcriptional activity and the lipidic makeup of these proliferated cells versus invaded monocytes. In a second part of this project, I will deploy adoptive bone marrow transfers from WT to Ubow mice and vice versa as a model to quantify intraplaque myeloid versus stromal-cell derived macrophages. I will compare proliferative capacity, phenotype, transcriptomics and lipidomics of these two subsets and link this information to their functionality. With this strategy I will be the first to reveal the impact of the three macrophage accumulation mechanisms throughout the disease course, to couple this to their function and to exploit this knowledge for targeted experimental therapeutic interventions.

Publications

List of publications.
year	authors and title	journal	last update
2017	Emiel P.C. van der Vorst, Kosta Theodorou, Yongzheng Wu, Marten A. Hoeksema, Pieter Goossens, Christina A. Bursill, Taghi Aliyev, Leonie F.A. Huitema, Sander W. Tas, Ine M.J. Wolfs, Marijke J.E. Kuijpers, Marion J. Gijbels, Casper G. Schalkwijk, Debby P.Y. Koonen, Shahla Abdollahi-Roodsaz, Kimberly McDaniels, Chih-Chieh Wang, Michael Leitges, Toby Lawrence, Jogchum Plat, Miranda Van Eck, Kerry-Anne Rye, Lhousseine Touqui, Menno P.J. de Winther, Erik A.L. Biessen, Marjo M.P.C. Donners High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-ÎºB/STAT1-IRF1 Signaling published pages: 197-207, ISSN: 1550-4131, DOI: 10.1016/j.cmet.2016.10.013	Cell Metabolism 25/1	2019-06-18
2017	Jan Nagenborg, Pieter Goossens, Erik A.L. Biessen, Marjo M.P.C. Donners Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: Implications for treatment published pages: 14-24, ISSN: 0014-2999, DOI: 10.1016/j.ejphar.2017.10.005	European Journal of Pharmacology 816	2019-06-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ATHERO MPH PROLIFERATION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ATHERO MPH PROLIFERATION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)